Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Tumour Growth Rate as a validated early radiological biomarker able to reflect treatment-induced changes in Neuroendocrine Tumours; the GREPONET-2 study.

Lamarca A, Ronot M, Moalla S, Crona J, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, Carvalho LFDP, Bezerra ROF, Borg P, Vietti Violi N, Vidal Trueba H, de Mestier L, Schaefer N, Baudin E, Sundin A, Costa FP, Pavel M, Dromain C.

Clin Cancer Res. 2019 Aug 2. pii: clincanres.0963.2019. doi: 10.1158/1078-0432.CCR-19-0963. [Epub ahead of print]

PMID:
31375514
2.

Angiomammography: A review of current evidences.

Dromain C, Vietti-Violi N, Meuwly JY.

Diagn Interv Imaging. 2019 Apr 5. pii: S2211-5684(19)30036-1. doi: 10.1016/j.diii.2019.01.011. [Epub ahead of print]

PMID:
30962168
3.

Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.

Lamarca A, Crona J, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, Carvhalo L, Franca Bezerra RO, Borg P, Vietti Violi N, Vidal Trueba H, de Mestier L, Schaefer N, Sundin A, Costa F, Pavel M, Dromain C; Knowledge Network.

Oncologist. 2019 Mar 25. pii: theoncologist.2018-0672. doi: 10.1634/theoncologist.2018-0672. [Epub ahead of print]

PMID:
30910869
4.

Patient respiratory-triggered quantitative T2 mapping in the pancreas.

Vietti Violi N, Hilbert T, Bastiaansen JAM, Knebel JF, Ledoux JB, Stemmer A, Meuli R, Kober T, Schmidt S.

J Magn Reson Imaging. 2019 Aug;50(2):410-416. doi: 10.1002/jmri.26612. Epub 2019 Jan 13.

PMID:
30637852
5.

Local recurrence rate in patients with colorectal cancer liver metastasis after wedge resection or percutaneous radiofrequency ablation.

Vietti Violi N, Duran R, Demartines N, Sempoux C, Guiu B, Bize PE, Sala N, Halkic N, Knebel JF, Denys A.

Int J Hyperthermia. 2018 Nov;34(7):1020-1028. doi: 10.1080/02656736.2017.1372644. Epub 2018 Mar 5.

PMID:
29506424
6.

Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.

Vietti Violi N, Duran R, Guiu B, Cercueil JP, Aubé C, Digklia A, Pache I, Deltenre P, Knebel JF, Denys A.

Lancet Gastroenterol Hepatol. 2018 May;3(5):317-325. doi: 10.1016/S2468-1253(18)30029-3. Epub 2018 Mar 2.

PMID:
29503247
7.

Hepatocellular carcinoma abutting large vessels: comparison of four percutaneous ablation systems.

Loriaud A, Denys A, Seror O, Vietti Violi N, Digklia A, Duran R, Trillaud H, Hocquelet A.

Int J Hyperthermia. 2018 Dec;34(8):1171-1178. doi: 10.1080/02656736.2018.1440017. Epub 2018 Apr 18.

PMID:
29457510
8.

Sildenafil as a therapeutic option for digital ischemic ulceration: case report.

Krähenbühl SM, Depairon M, Faure M, Vietti Violi N, Applegate LA, Raffoul W.

J Hand Surg Am. 2015 May;40(5):890-3. doi: 10.1016/j.jhsa.2015.01.041. Epub 2015 Mar 25.

9.

Prevalence and clinical importance of mesenteric venous thrombosis in the Swiss Inflammatory Bowel Disease Cohort.

Violi NV, Schoepfer AM, Fournier N, Guiu B, Bize P, Denys A; Swiss Inflammatory Bowel Disease Cohort Study Group.

AJR Am J Roentgenol. 2014 Jul;203(1):62-9. doi: 10.2214/AJR.13.12447. Erratum in: AJR Am J Roentgenol. 2014 Aug;203(2):463.

PMID:
24951196
10.

Acute mesenteric vein thrombosis: factors associated with evolution to chronic mesenteric vein thrombosis.

Vietti Violi N, Fournier N, Duran R, Schmidt S, Bize P, Guiu B, Denys A.

AJR Am J Roentgenol. 2014 Jul;203(1):54-61. doi: 10.2214/AJR.13.11527.

PMID:
24951195

Supplemental Content

Loading ...
Support Center